About this trial
Cardiovascular diseases represent one of the leading causes of morbidity and mortality worldwide. Prevention in patients at cardiovascular risk is essential to reduce the incidence of cardiovascular events and slow the progression of risk.
This study aims to evaluate the effectiveness and feasibility of a cardiovascular prevention pathway delivered remotely through a digital application, comparing it with a traditional in-person care pathway.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age between 40 and 75 years
hypertension
hyperglycaemia
type 2 diabetes not requiring insulin therapy
Disqualifiers
previous myocardial infarction
stroke
transient ischemic attack
coronary artery diseas
Trial design
Parallel
Treatments tested in this trial
Recommendations to the patient.
Other interventionRecommendations to the patient
Treatment groups
Trial outcomes
Primary outcomes
Blood pressure
Systolic and diastolic in millimeters of mercury
number of cigarettes
Secondary outcomes
body weigh
number of daily steps
Sponsors and contacts
Click on the lead sponsor to view all of their trials.